Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Katsuyoshi Kawashima is active.

Publication


Featured researches published by Katsuyoshi Kawashima.


Folia Pharmacologica Japonica | 1978

止瀉剤Loperamideの薬理学的研究(第3報)モルモット生体位腸管のProstaglandin E1およびAcetylcholineによる腸運動ならびに摘出腸管の各種Agonistによる収縮におよぼす影響

Yukinobu Sohji; Katsuyoshi Kawashima; Masanao Shimizu

To clarify the mode of action of loperamide, the interaction with various agonists was investigated in guinea pig intestines. The following results were obtained. Prostaglandin E1 (0.1 microgram) or acetylcholine (1 approximately 3 microgram) injection into the mesenteric artery at 10 min intervals caused a constant rise of intraluminal pressure of the intestinal loop in situ. Loperamide (0.01 approximately 0.1 mg/kg i.v.) markedly suppressed the response induced by prostaglandin E1. Morphine (0.1 approximately 1.0 mg/kg i.v.) and atropine (0.01 mg/kg i.v.) also suppressed the response. The intestinal response induced by acetylcholine was inhibited markedly by atropine and slightly by loperamide (0.1 mg/kg i.v.) but not by morphine. Contractions of the isolated ileum induced by coaxial stimulation, BaCl2, nicotine and serotonin were suppressed by loperamide (10(-9) approximately 2 X 10(-7) g/ml). Morphine, methadone and codeine showed the same effect as loperamide but the activity was weaker than that of loperamide. Contractions of isolated ileum induced by acetylcholine, histamine and bradykinin, and Ca-contraction in the depolarized taenia coli were inhibited by relatively high concentrations of loperamide (2 X 10(-7) g/ml or above). These results suggest that loperamide suppresses the function of cholinergic neurons in the intestines.


Chemical & Pharmaceutical Bulletin | 1989

A Novel Class of Antiulcer Agents. 4-Phenyl-2-(1-piperazinyl)quinolines

Katsuhiko Hino; Katsuyoshi Kawashima; Makoto Oka; Yasutaka Nagai; Hitoshi Uno; Jun-Ichi Matsumoto


Chemical & Pharmaceutical Bulletin | 1983

Synthesis and spasmolytic activity of 2-substituted-3-(.OMEGA.-dialkylaminoalkoxyphenyl)acrylonitriles and related compounds.

Shunsuke Naruto; Hiroyuki Mizuta; Toyokichi Yoshida; Hitoshi Uno; Katsuyoshi Kawashima; Toshiaki Kadokawa; Haruki Nishimura


Archive | 1982

2-Cyclic amino-2-(1,2-benzisoxazol-3-yl)acetic acid ester derivatives, process for the preparation thereof and composition containing the same

Haruki Nishimura; Shunsuke Naruto; Hiroyuki Mizuta; Toshiaki Kadokawa; Katsuyoshi Kawashima


Chemical & Pharmaceutical Bulletin | 1989

Synthesis and Antiucler Activity of the Metabolites of 2-(4-Ethyl-1-piperazinyl)-4-phenylquinoline Dimaleate(AS-2646), a Novel Gastric Antisecretory and Antiulcer Agent

Katsuhiko Hino; Katsuyoshi Kawashima; Makoto Oka; Hitoshi Uno; Jun-Ichi Matsumoto


Archive | 1985

2-(1-piperazinyl)-4-substituted phenylquinoline derivatives, processes for the preparation thereof, and pharmaceutical composition containing the same

Hitoshi Uno; Katsuhiko Hino; Toshiaki Kadokawa; Katsuyoshi Kawashima


Journal of Medicinal Chemistry | 1982

Synthesis and spasmolytic activities of 2-(1,2-benzisoxazol-3-yl)-3-[[omega-(dialkylamino)alkoxy]phenyl]acrylonitriles.

Shunsuke Naruto; Hiroyuki Mizuta; Tadahiro Sawayama; Toyokichi Yoshida; Hitoshi Uno; Katsuyoshi Kawashima; Yukinobu Sohji; Toshiaki Kadokawa; Haruki Nishimura


Japanese Journal of Pharmacology | 1982

A possible mechanism of a new antispasmodic drug,2-(1,2-benzisoxazol-3-yl)-3-(2-(2-piperidinoethoxy) phenyl)acrylonitrile (SX-284).

Issei Takayanagi; Hideko Sone; Katsuyoshi Kawashima; Yukinobu Sohji; Toshiaki Kadokawa


Archive | 1988

Anti-peptic ulcer agent

Toshiaki Kadokawa; Katsuyoshi Kawashima


Chemical & Pharmaceutical Bulletin | 1987

Synthesis and spasmolytic activity of aminoalkyl 2-substituted-2-(1,2-benzisoxazol-3-yl)acetates.

Shunsuke Naruto; Shozo Ueda; Toyokichi Yoshida; Hiroyuki Mizuta; Katsuyoshi Kawashima; Toshiaki Kadokawa

Collaboration


Dive into the Katsuyoshi Kawashima's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge